Literature DB >> 12648667

Negative receptor signalling.

Ivan Dikic1, Silvia Giordano.   

Abstract

Binding of external factors to cell membrane receptors triggers intracellular signalling pathways that ultimately determine if the cell proliferates, differentiates or undergoes apoptosis. Activated receptors also initiate a cascade of events, called negative receptor signalling, that decreases the amplitude of positive signals and modulates the level of cell stimulation. Recent studies have revealed that negative signalling by receptor tyrosine kinases involves coordinated action of ubiquitin ligases (i.e. Cbl), adaptor proteins (i.e. Grb2 and CIN85), inhibitory molecules (i.e. Sprouty), cytoplasmic kinases (i.e. activated Cdc42-associated kinase) and phosphoinositol metabolites. These inhibitory signals are essential for normal cell functioning, and their deregulation often results in human diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12648667     DOI: 10.1016/s0955-0674(03)00004-8

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  104 in total

1.  A critical role of c-Cbl-interacting protein of 85 kDa in the development and progression of head and neck squamous cell carcinomas through the ras-ERK pathway.

Authors:  Takahiro Wakasaki; Muneyuki Masuda; Hiroaki Niiro; Siamak Jabbarzadeh-Tabrizi; Kumiko Noda; Tadayoshi Taniyama; Shizuo Komune; Koichi Akashi
Journal:  Neoplasia       Date:  2010-10       Impact factor: 5.715

Review 2.  Defective downregulation of receptor tyrosine kinases in cancer.

Authors:  Kristi G Bache; Thomas Slagsvold; Harald Stenmark
Journal:  EMBO J       Date:  2004-07-01       Impact factor: 11.598

3.  CIN85 associates with multiple effectors controlling intracellular trafficking of epidermal growth factor receptors.

Authors:  Katarzyna Kowanetz; Koraljka Husnjak; Daniela Höller; Marcin Kowanetz; Philippe Soubeyran; Dianne Hirsch; Mirko H H Schmidt; Kresimir Pavelic; Pietro De Camilli; Paul A Randazzo; Ivan Dikic
Journal:  Mol Biol Cell       Date:  2004-04-16       Impact factor: 4.138

4.  Mutation analysis of CBL-C and SPRED3 on 19q in human glioblastoma.

Authors:  Masahiro Mizoguchi; Catherine L Nutt; David N Louis
Journal:  Neurogenetics       Date:  2003-11-14       Impact factor: 2.660

Review 5.  The ERBB network: at last, cancer therapy meets systems biology.

Authors:  Yosef Yarden; Gur Pines
Journal:  Nat Rev Cancer       Date:  2012-07-12       Impact factor: 60.716

6.  SH3KBP1-binding protein 1 prevents epidermal growth factor receptor degradation by the interruption of c-Cbl-CIN85 complex.

Authors:  Lifeng Feng; Jin-Tao Wang; Hongchuan Jin; Kaixian Qian; Jian-Guo Geng
Journal:  Cell Biochem Funct       Date:  2011-08-09       Impact factor: 3.685

7.  PTP1B targets the endosomal sorting machinery: dephosphorylation of regulatory sites on the endosomal sorting complex required for transport component STAM2.

Authors:  Matthew Stuible; Jasmine V Abella; Matthew Feldhammer; Misha Nossov; Veena Sangwan; Blagoy Blagoev; Morag Park; Michel L Tremblay
Journal:  J Biol Chem       Date:  2010-05-26       Impact factor: 5.157

8.  Loss of T-cell protein tyrosine phosphatase induces recycling of the platelet-derived growth factor (PDGF) beta-receptor but not the PDGF alpha-receptor.

Authors:  Susann Karlsson; Katarzyna Kowanetz; Asa Sandin; Camilla Persson; Arne Ostman; Carl-Henrik Heldin; Carina Hellberg
Journal:  Mol Biol Cell       Date:  2006-09-13       Impact factor: 4.138

9.  Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer.

Authors:  Aleksandra Franovic; Lakshman Gunaratnam; Karlene Smith; Isabelle Robert; David Patten; Stephen Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-01       Impact factor: 11.205

10.  Essential role of c-Cbl in amphiregulin-induced recycling and signaling of the endogenous epidermal growth factor receptor.

Authors:  Aleksander Baldys; Monika Göoz; Thomas A Morinelli; Mi-Hye Lee; John R Raymond; Louis M Luttrell; John R Raymond
Journal:  Biochemistry       Date:  2009-02-24       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.